Diagnosis of factor XIII deficiency

Hematology

Volumn 21, Issue 7, 2016, Pages 430-439

  Dorgalaleh, Akbar ^a   Tabibian, Shadi ^b   Hosseini, Maryam Sadat ^b   Farshi, Yadolla ^b   Roshanzamir, Fateme ^b   Naderi, Majid ^c   Kazemi, Ahmad ^a   Zaker, Farhad ^d   Aghideh, Ali Noroozi ^b   Shamsizadeh, Morteza ^e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Factor XIII deficiency; Laboratory diagnosis; Rare bleeding disorder

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 A2; BLOOD CLOTTING FACTOR 13 B2; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13A2B2; BLOOD CLOTTING FACTOR 13B; FIBRINOGEN; HEPARIN; UNCLASSIFIED DRUG;

BIOASSAY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD SAMPLING; BLOT SOLUBILITY ASSAY; CRYOPRECIPITATION; DNA SEQUENCE; ENZYME ACTIVITY; GENE; HUMAN; MOLECULAR DIAGNOSIS; PHOTOMETRY; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; FACTOR XIII DEFICIENCY;

FACTOR XIII DEFICIENCY; HUMANS;

EID: 84978483956     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245332.2015.1101975     Document Type: Review

References (74)

1. I.Komaromi, Z.Bagoly, L.Muszbek. Factor XIII: novel structural and functional aspects. J Thromb Haemost. 2011;9(1):9–20. doi: 10.1111/j.1538-7836.2010.04070.x
2. B.Hoppe. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation. Thromb Haemost. 2014;112(6):649–58. doi: 10.1160/TH14-01-0085
3. Z.Bagoly, Z.Koncz, J.Hársfalvi, L.Muszbek. Factor XIII, clot structure, thrombosis. Thromb Res. 2012;129(3):382–7. doi: 10.1016/j.thromres.2011.11.040
4. L.Lorand. Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost. 2005;3(7):1337–48. doi: 10.1111/j.1538-7836.2005.01213.x
5. H.P.Kohler. Interaction between FXIII and fibrinogen. Blood. 2013;121(11):1931–2. doi: 10.1182/blood-2013-01-479055
6. A. Dorgalaleh, S. Tabibian, S. Hosseini, M. Shamsizadeh Guidelines for laboratory diagnosis of factor XIII deficiency. Blood Coagulation and Fibrinolysis. 2016:27(4), 361-364. DOI:10.1097/MBC.0000000000000459.
7. M. Naderi, A. Dorgalaleh, S. Tabibian, S. Alizadeh, P. Eshghi, G. Solaimani. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol. 2013;3(4):164–72.
8. R.A.Ariëns, T.-S.Lai, J.W.Weisel, C.S.Greenberg, P.J.Grant. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002;100(3):743–54. doi: 10.1182/blood.V100.3.743
9. Z.Bagoly, É.Katona, L.Muszbek. Factor XIII and inflammatory cells. Thromb Res. 2012;129:S77–81. doi: 10.1016/j.thromres.2012.02.040
10. A.Lawrie, L.Green, I.Mackie, R.Liesner, S.Machin, F.Peyvandi. Factor XIII–an under diagnosed deficiency–are we using the right assays? J Thromb Haemost. 2010;8(11):2478–82. doi: 10.1111/j.1538-7836.2010.04028.x
11. H.Kohler, A.Ichinose, R.Seitz, R.Ariens, L.Muszbek. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011;9(7):1404–6. doi: 10.1111/j.1538-7836.2011.04315.x
12. V.Schroeder, H.Handrková, J.Dodt, H.P.Kohler. Free factor XIII activation peptide affects factor XIII function. Br J Haematol. 2014.
13. L.Muszbek, Z.Bereczky, Z.Bagoly, I.Komáromi, É.Katona. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011;91(3):931–72. doi: 10.1152/physrev.00016.2010
14. A.Dorgalaleh, M.Naderi, M.Shamsizadeh. Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency. Ann Hematol. 2016:95(3), 451–455. DOI:10.1007/s00277-015-2568-8.
15. M.Naderi, T.Zarei, S.Haghpanah, P.Eshghi, E.Miri-Moghaddam, M.Karimi. Intracranial hemorrhage pattern in the patients with factor XIII deficiency. Ann Hematol. 2014;93(4):693–7. doi: 10.1007/s00277-013-1918-7
16. M.Naderi, A.Dorgalaleh, S.Alizadeh, Z.Kashani Khatib, S.Tabibian, A.Kazemi, Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency. Haemophilia. 2014;20(1):e89–92. doi: 10.1111/hae.12287
17. P.Eshghi, S.Mahjour, M.Naderi, J.Dehbozorgian, M.Karimi. Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran. Haemophilia. 2010;16(2):383–5. doi: 10.1111/j.1365-2516.2009.02134.x
18. J.H.Levy, C.Greenberg. Biology of factor XIII and clinical manifestations of factor XIII deficiency. Transfusion. 2013;53(5):1120–31. doi: 10.1111/j.1537-2995.2012.03865.x
19. V.Ivaskevicius, A.Biswas, C.Bevans, V.Schroeder, H.P.Kohler, H.Rott, Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica. 2010;95(6):956–62. doi: 10.3324/haematol.2009.017210
20. M.Mahmoodi, F.Peyvandi, A.Afrasiabi, F.Ghaffarpasand, M.Karimi. Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis. 2011;22(5):396–401. doi: 10.1097/MBC.0b013e328345f566
21. I.Jennings, S.Kitchen, T.Woods, F.Preston. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost. 2003;1(12):2603–8. doi: 10.1046/j.1538-7836.2003.00469.x
22. E.J.Favaloro, G.Lippi, D.M.Adcock. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?. Semin Thromb Hemost. 2008;34(7):612–34. doi: 10.1055/s-0028-1104540
23. E.Katona, K.Penzes, E.Molnar, L.Muszbek. Measurement of factor XIII activity in plasma. Clin Chem Lab Med. 2012;50(7):1191–202. doi: 10.1515/cclm-2011-0730
24. C.P.Hayward, K.A.Moffat, W.Lim. Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: reply to a rebuttal. J Thromb Haemost. 2005;3(1):187–8. doi: 10.1111/j.1538-7836.2004.01093.x
25. G.Lippi, G.L.Salvagno, M.Montagnana, G.Lima-Oliveira, G.C.Guidi, E.J.Favaloro. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost. 2012;38(6):565–75. doi: 10.1055/s-0032-1315961
26. G.Lima-Oliveira, G.Lippi, G.L.Salvagno, M.Montagnana, G.Picheth, G.C.Guidi. Sodium citrate vacuum tubes validation: preventing preanalytical variability in routine coagulation testing. Blood Coagul Fibrinolysis. 2013;24(3):252–5. doi: 10.1097/MBC.0b013e32835b72ea
27. Z.Fadoo, Q.Merchant, K.A.Rehman. New developments in the management of congenital Factor XIII deficiency. J Blood Med. 2013;4:65–73. doi: 10.2147/JBM.S32693
28. S.Shanbhag, S.Shetty, B.Kulkarni, K.Ghosh. An improved, semi quantitative clot based assay for factor XIII. Haemophilia. 2011;17(4):718–20. doi: 10.1111/j.1365-2516.2010.02456.x
29. A.Tahlan, J.Ahluwalia. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit. Arch Pathol Lab Med. 2014;138(2):278–81. doi: 10.5858/arpa.2012-0639-RS
30. A.E.Lovejoy, T.C.Reynolds, J.E.Visich, M.D.Butine, G.Young, M.A.Belvedere, Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood. 2006;108(1):57–62. doi: 10.1182/blood-2005-02-0788
31. R.Anwar, K.J.Miloszewski. Factor XIII deficiency. Br J Haematol. 1999;107(3):468–84. doi: 10.1046/j.1365-2141.1999.01648.x
32. P.Bolton-Maggs, E.Favaloro, A.Hillarp, I.Jennings, H.Kohler. Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders. Haemophilia. 2012;18(s4):66–72. doi: 10.1111/j.1365-2516.2012.02830.x
33. S.Ghosh, P.McEvoy, B.McVerry. Idiopathic autoantibody that inhibits fibrin monomer polymerization. Br J Haematol. 1983;53(1):65–72. doi: 10.1111/j.1365-2141.1983.tb01987.x
34. E.Jakobsen, H.Godal. Simple, Semiquantitative test for partial factor XI11 (FSF) deficiency. Scand J Haematol. 1974;12(5):366–8. doi: 10.1111/j.1600-0609.1974.tb00222.x
35. J.Francis The detection and measurement of factor XIII activity: a review. Med Lab Sci. 1980;37(2):137–47.
36. V.Schroeder, D.Durrer, E.Meili, G.Schubiger, H.P.Kohler. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss medical weekly. 2007;137(19-20):272–8.
37. H.Kamitsuji, K.Tani, M.Yasui, A.Taniguchi, K.Taira, S.Tsukada, Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch–Schönlein purpura. Eur J Pediatr. 1987;146(5):519–23. doi: 10.1007/BF00441608
38. I.Mackie, P.Cooper, A.Lawrie, S.Kitchen, E.Gray, M.Laffan. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol. 2013;35(1):1–13. doi: 10.1111/ijlh.12004
39. P.Eshghi, N.Cohan, M.Naderi, M.Karimi. Factor XIII deficiency: a review of literature. IJBC. 2012;4(2):85–91.
40. W.Lim, K.Moffat, C.M Hayward. Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency. J Thromb Haemost. 2004;2(6):1017–9. doi: 10.1111/j.1538-7836.2004.00728.x
41. A.Ichinose, T.Osaki, M.Souri. Clinical features of 32 new Japanese cases with autoimmune haemorrha-philia due to anti-factor XIII antibodies. Haemophilia. 2015 Sep;21(5):653–8.
42. L.Karpati, B.Penke, E.Katona, I.Balogh, G.Vamosi, L.Muszbek. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem. 2000;46(12):1946–55.
43. E.Ajzner, L.Muszbek. Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency: a rebuttal. J Thromb Haemost. 2004;2(11):2075–7. doi: 10.1111/j.1538-7836.2004.00986.x
44. Y.Nishida, S.Ikematsu, K.Fukutake, M.Fujimaki, K.Fukutake, E.Kakishita. A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtration. Thromb Res. 1984;36(2):123–31. doi: 10.1016/0049-3848(84)90334-7
45. K.Oertel, A.Hunfeld, E.Specker, C.Reiff, R.Seitz, R.Pasternack, A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem. 2007;367(2):152–8. doi: 10.1016/j.ab.2007.05.011
46. É.Katona, G.Haramura, L.Kárpáti, J.Fachet, L.Muszbek. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A 2 B 2). Thromb Haemost. 2000;83(2):268–73.
47. K.N.Parameswaran, X.F.Cheng, E.C.Chen, P.T.Velasco, J.H.Wilson, L.Lorand. Hydrolysis of gamma: epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem. 1997;272(15):10311–7. doi: 10.1074/jbc.272.15.10311
48. H.Yorifuji, K.Anderson, G.W.Lynch, L.Van De Water, J.McDonagh. B protein of factor XIII: differentiation between free B and complexed B. Blood. 1988;72(5):1645–50.
49. É.Katona, É.Ajzner, K.Tóth, L.Kárpáti, L.Muszbek. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods. 2001;258(1):127–35. doi: 10.1016/S0022-1759(01)00479-3
50. C.S.Greenberg, J.V.Dobson, C.C.Miraglia. Regulation of plasma factor XIII binding to fibrin in vitro. Blood. 1985;66(5):1028–34.
51. Y.Luo, G.Zhang, W.Zuo, W.Zheng, C.Dai. Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure. Ann Hematol. 2010;89(8):833–4. doi: 10.1007/s00277-009-0868-6
52. M.Franchini, P.M.Mannucci. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Br J Clin Pharmacol. 2011;72(4):553–62. doi: 10.1111/j.1365-2125.2010.03899.x
53. J.E.Graham, W.J.Yount, H.R.Roberts. Immunochemical characterization of a human antibody to factor XIII. Blood. 1973;41(5):661–9.
54. Y.Y.Luo, G.S.Zhang. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination. Haemophilia. 2011;17(3):393–8. doi: 10.1111/j.1365-2516.2010.02459.x
55. P.T.Otis, D.I.Feinstein, S.I.Rapaport, M.J.Patch. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations. Blood. 1974;44(6):771–81.
56. R.Krumdieck, D.R.Shaw, S.T.Huang, M.-C.Poon, P.K.Rustagi. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia. Am J Med. 1991;90(1):639–45. doi: 10.1016/0002-9343(91)90643-C
57. T.F.Gregory, B.Cooper. Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent). 2006;19(3):221–23.
58. A.Srivastava, A.Brewer, E.Mauser-Bunschoten, N.Key, S.Kitchen, A.Llinas, Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1–47. doi: 10.1111/j.1365-2516.2012.02909.x
59. R.Kessel, C.Hu, L.Shore-Lesserson, J.Rand, D.Manwani. A child with acquired factor XIII deficiency: case report and literature review. Haemophilia. 2013;19(6):814–26. doi: 10.1111/hae.12145
60. C.Blancher, A.Jones SDS-PAGE and western blotting techniques. Metastasis Research Protocols: Springer; 2001. p. 145–62.
61. C.Miller, S.Platt, A.Rice, F.Kelly, J.Soucie. Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance. J Thromb Haemost. 2012;10(6):1055–61. doi: 10.1111/j.1538-7836.2012.04705.x
62. R.Anwar, A.D.Stewart, K.J.Miloszewski, M.S.Losowsky, A.F.Markham. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol. 1995;91(3):728–35. doi: 10.1111/j.1365-2141.1995.tb05376.x
63. A.Biswas, V.Ivaskevicius, R.Seitz, A.Thomas, J.Oldenburg. An update of the mutation profile of Factor 13 A and B genes. Blood Rev. 2011;25(5):193–204. doi: 10.1016/j.blre.2011.03.001
64. A.R.Green. Postgraduate haematology. London: John Wiley & Sons; 2010.
65. V.Ivaskevicius, J.Windyga, B.Baran, V.Schroeder, J.Junen, K.Bykowska, Phenotype–genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia. 2007;13(5):649–57. doi: 10.1111/j.1365-2516.2007.01517.x
66. B.P.Kulkarni, S.B.Nair, M.Vijapurkar, L.Mota, S.Shanbhag, S.Ali, Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review. PLoS ONE. 2014;9(10):e108683-1–16.
67. E.Gomez Garcia, S.Poort, J.Stibbe, A.Sturk, M.Schaap, M.Kappers, Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency. Br J Haematol. 2001;112(2):513–8. doi: 10.1046/j.1365-2141.2001.02577.x
68. M.Naderi, A.Dorgalaleh, S.Alizadeh, S.Tabibian, S.Hosseini, M.Shamsizadeh, Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hemato. 2014;100(5):443–9. doi: 10.1007/s12185-014-1664-1
69. M.Naderi, S.Alizadeh, A.Kazemi, S.Tabibian, F.Zaker, T.Bamedi, Central nervous system bleeding in pediatric patients with factor XIII deficiency: A study on 23 new cases. Hematology. 2015;20(2):112–8. doi: 10.1179/1607845414Y.0000000172
70. P.Eshghi, N.Cohan, M.Lak, M.Naderi, F.Peyvandi, M.Menegatti, Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran. Clin Appl Thromb Hemost. 2012;18(1):100–3. doi: 10.1177/1076029611412363
71. A.Goodeve. Laboratory methods for the genetic diagnosis of bleeding disorders. Clin Lab Haematol. 1998;20(1):3–19. doi: 10.1046/j.1365-2257.1998.00115.x
72. A.Dalal, M.Pradhan, S.Agarwal. Genetics of bleeding disorders. Int J Human Genet. 2006;6(1):27–32.
73. F.Peyvandi, T.Kunicki, D.Lillicrap. Genetic sequence analysis of inherited bleeding diseases. Blood. 2013;122(20):3423–31. doi: 10.1182/blood-2013-05-505511
74. C.J.Killick, C.J.Barton, S.Aslam, G.Standen. Prenatal diagnosis in factor XIII-A deficiency. Arch Dis Child Fetal Neonatal Ed. 1999;80(3):F238–9. doi: 10.1136/fn.80.3.F238